INNOVA CAPTAB
Back to Balance Sheet
|
INNOVA CAPTAB Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹23 Cr | ₹0.95 Cr | ₹-15 Cr | ₹3.80 Cr | ₹1.84 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of INNOVA CAPTAB ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹23 Cr |
| Mar2025 | ₹0.95 Cr |
| Mar2024 | ₹-15 Cr |
| Mar2023 | ₹3.80 Cr |
| Mar2022 | ₹1.84 Cr |
How is Deferred Tax Assets / Liabilities of INNOVA CAPTAB Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹23 Cr | 2,305.05 | |
| Mar2025 | ₹0.95 Cr | Positive | |
| Mar2024 | ₹-15 Cr | Negative | |
| Mar2023 | ₹3.80 Cr | 106.91 | |
| Mar2022 | ₹1.84 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹5,398.3 Cr | -3.1% | 0.3% | 4.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | -3.1% |
0.3% |
4.4% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses